×
Time:2024-01-13
Recently, NHU has secured approval for domestic drug registration of its API Coenzyme Q10, positioning the company as the first enterprise to receive such approval since the issuance of the National Medical Products Administration (NMPA)'s Announcement on Matters Related to Further Improving the Review, Approval, and Supervision of Drugs in 2019. This significant milestone indicates that our Coenzyme Q10 is at the forefront of the industry and paves the way for a new API market, presenting fresh opportunities for our development.
About Coenzyme Q10
Coenzyme Q10, a fat-soluble antioxidant, plays a crucial role in fortifying the myocardium, preventing heart aging, preventing and combating cancer, maintaining cardiovascular health, and enhancing overall vitality. The significant market demand for Coenzyme Q10 exists both domestically and internationally. The production of API Coenzyme Q10 necessitates stringent quality control and safety inspections, leading to rigorous requirements for production processes and product quality. NHU stands out as the inaugural company to receive such approval and recognition, demonstrating the company’s capability to produce high-quality API Coenzyme Q10 since the drug approval reform by the NMPA in 2019.
In its role as a guardian of nutrition and health, NHU is committed to the journey of open innovation. Starting from addressing future and potential market needs, we collaborate with academia and industry to delve into the cutting edges of chemical and biological science and technology and foster innovation and advancement, leading to the successful development of products like the Vitamin Series, Moxifloxacin Hydrochloride, and Taurine. NHU aims to create value for the entire industry and society, establishing a "Safety Moat" for human health.
The Shenzhen Stock Exchange recently released the results of its 2024–2025 information disclosure assessment for listed companies. Thanks to our well-regulated operations and high-quality disclosure practices, NHU once again received the top “A” rating.
View details
On November 20, at the 9th Forum on Enterprise High-Quality Development and Management Innovation held at Zhejiang University, we were once again honored with a place on the “2025 Top 30 Zhejiang Listed Companies for Best Internal Control”.
View details
From October 8 to 10, NHU made a prominent appearance at the 2025 Vietnam Livestock Exhibition (VIETSTOCK). This participation marks a significant step for the company in deepening its presence in the Southeast Asian market and enhancing its brand influence in Vietnam’s feed and livestock industry. As Vietnam’s largest and most professional livestock event, the exhibition was successfully held in Ho Chi Minh City, providing NHU with an excellent platform to showcase its strengths and expand regional cooperation.
View details